UGN-103 Shows Durable Disease Control in LG-IR-NMIBC, Paving Path for FDA SubmissionByJason M. BroderickMay 15th 2026
FDA Grants Fast Track Designation to Suplexa for MSI-H Colorectal CancerByJason M. BroderickMay 15th 2026
Oncologists Weigh Real-World Nuances in First-Line Gastric CancerByTargeted Oncology StaffMay 14th 2026